New from the FDA: ✅ Moderna and J&J booster shots authorized ✅ You can mix and match Covid vaccines
A vial of the Johnson & Johnson Covid-19 vaccine is shown at a hospital in Bay Shore, N.Y. on March 3. | Mark Lennihan/AP PhotoThe Food and Drug Administration has authorized the use of Covid-19 boosters from Moderna and Johnson & Johnson, and says that people can receive a different brand of vaccine as a booster than they did for their initial shots.
Those eligible for the Moderna booster include people 65 and older and those 18-64 at high risk of severe Covid-19 or with high exposure to the coronavirus through their jobs or living situations. The Moderna booster can be given six months after initial vaccination. The Johnson & Johnson booster will now be available to anyone 18 or older two months after their first dose.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Relief, eager anticipation for many Americans ahead of FDA decision on booster shotsThe FDA is expected to decide as early as Wednesday whether the 15 million Americans who got the single-dose J&J shot by Janssen Pharmaceutical Companies should get a second dose.
Lire la suite »
FDA may soon approve mixing and matching COVID booster shotsThe Food and Drug Administration is moving to soon allow people to receive booster shots that are different from their first COVID-19 vaccine doses, people...
Lire la suite »
The FDA Plans to Allow Americans to 'Mix and Match' BoostersThe FDA Plans to Allow Americans to 'Mix and Match' Boosters, But Should You Do It?
Lire la suite »
Sage, Biogen now plan to submit depression drug candidate to FDA in second half of 2022Shares of Sage Therapeutics Inc. undefined gained 0.5% in premarket trading on Wednesday, the day after the company said it and Biogen Inc. undefined plan to...
Lire la suite »
FDA expected to allow 'mix and match' for Covid-19 vaccine boostersTwo sources confirmed reporting that the federal agency plans to allow using a different vaccine type from the one used in initial doses.
Lire la suite »